# Just Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/just-medical

- Industry: Medical Devices & Equipment
- Headquarters: Tianjin, China
- Website: www.justmedical.cn
- Total disclosed funding: $14M
- Latest round: Series B (May 8, 2021)
- Investors on record: 7

## About

Established in 2004 and based in Tianjin, China, Just Medical is a manufacturer of orthopedic medical equipment. The company's business scope includes implantable devices (orthopedic internal fixation devices, cerebral aneurysm clips), implantable artificial organs (artificial joints), etc.

Based on the research and development of patented technologies in the field of orthopedics and related medical materials, Just Medical provides users with artificial hip joints, artificial knee joints, trauma internal fixation products, spinal internal fixation products and orthopedic surgical instruments. Just Medical has developed the world's first trabecular femoral stem and trabecular total hip joint, developed a movable platform type single-compartment knee prosthesis system, and developed products such as cartilage repair agents for injection. The EPS joint surgery robot developed by Special Medical aims to change the status quo of joint surgery. Just Medical conducts product quality control from raw materials, semi-finished products, process inspection, and finished product inspection to provide safe and effective products for the market.

In the future, the company will continue to focus on the step-by-step prevention and treatment of joint diseases, focusing on artificial intelligence, 3D printing, new material applications, and regenerative medicine. The first phase of the artificial joint intelligent demonstration factory project with an investment of hundreds of millions of yuan by Just Medical will be officially opened in June 2021, and it is expected to increase production efficiency by 5 times.

## Funding rounds

- Series B, May 8, 2021 — Qiming Venture Partners, YuanBio Venture, LYFE Capital, SDIC Unity Capital, Fangyuan Rongtong Fund, Tasly Holding Group
- Series A, Aug 30, 2019, $14M — YuanBio Venture, LYFE Capital, Fangyuan Rongtong Fund, Tasly Holding Group, Chongqing Boyi Equity Investment Fund Management

## Investors

- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series A, Series B
- LYFE Capital — Series A, Series B
- Fangyuan Rongtong Fund (https://capitalatlas.ai/funds/fangyuan-rongtong-fund) — Series A, Series B
- Tasly Holding Group — Series A, Series B
- Chongqing Boyi Equity Investment Fund Management — Series A
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series B
- SDIC Unity Capital (https://capitalatlas.ai/funds/sdic-unity-capital) — Series B